NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AquaPass Medical Ltd.

AquaPass Medical Ltd.

Private
IsraelHealthcare & Life Scienceshttps://aquapass-medical.com/

Last Round

Seed

Jul 1, 2019

Company Overview

AquaPass Medical Ltd. is a medical technology company that develops a non-invasive, drug-free system designed to treat fluid overload in patients with heart failure and chronic kidney disease by enhancing the body's natural perspiration process.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicefluid overloadheart failurechronic kidney diseaseedema managementwearable medical devicediuretic therapynon-invasive therapyinterstitial fluid removalmedtechCKDdigital healthclinical trialshospital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AquaPass Medical Ltd. Comparables

Compare AquaPass Medical Ltd. with similar companies based on industry and business-model similarity.

AquaPass Medical Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Paragate Medical
78%
Selera Medical
71%
CardioRenal Systems
69%

AquaPass Medical Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2019

Key People

Founding team and executive leadership

Noam Josephy

Chief Executive Officer

Executive Team

Yaacov Nitzan

Founder CEO (2020-2025) & CTO

Founding Team

AquaPass Medical Ltd. Investors

Notable investors and investment history

AquaPass Medical Ltd. investors
InvestorRounds
BRM GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 16, 2026

    Grew 22% QoQ, from 18 to 22 employees.

  • Dec 23, 2025

    Grew 17% QoQ, from 18 to 21 employees.

AquaPass Medical Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AquaPass Medical Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AquaPass Medical Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range20
Year Founded2019
Last FundingJul 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.